Home
Scholarly Works
TLE3 is not a predictive biomarker for taxane...
Conference

TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial

Authors

Bartlett JMS; Nielsen TO; Gao D; Gelmon KA; Quintayo MA; Starczynski J; Han L; Burnell MJ; Levine MN; Shepherd LE

Volume

75

Publisher

AMER ASSOC CANCER RESEARCH

Publication Date

May 1, 2015

Name of conference

37th Annual CTRC-AACR San Antonio Breast Cancer Symposium

Conference place

San Antonio, TX

Conference start date

December 9, 2014

Conference end date

December 13, 2014

Conference proceedings

CANCER RESEARCH

ISSN

0008-5472

Contact the Experts team